Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Rabbit Polyclonal (IgG) to Mouse IRAK3 / IRAKM / IRAK-M
Mouse, Human, Rat
IHC - Paraffin, ICC, Western blot
Goat Polyclonal to Mouse IRAK3 / IRAKM / IRAK-M
Mouse, Rat, Hamster
Western blot, ELISA
Mouse IRAK3 / IRAKM / IRAK-M
Mouse, Rat, Hamster (tested or 100% immunogen sequence identity)
Western blot (1:64000) & (0.05 - 0.2 µg/ml)
Specificity and Use
IRAK3 / IRAKM / IRAK-M antibody was raised against synthetic peptide C-GHSYGSKPMEKR from an internal region (near the C-terminus) of mouse IRAK3 / IRAKM (NP_082955.2). Percent identity by BLAST analysis: Mouse, Hamster (100%); Rat (92%).
LS-E26773 - Lyophilized - 100 µg - $145.00
Immunizing peptide used to generate LS-C55010. Useful for pre-absorption and neutralization of the antibody's antigen binding site.
IRAK3 Antibody, ASRT5 Antibody, IRAK M Antibody, IRAK-3 Antibody, IL1RAK M Antibody, IRAK-M Antibody, IRAKM Antibody
IRAK3 / IRAKM / IRAK-M is a member of the interleukin-1 receptor-associated kinase protein family. Members of this family are essential components of the Toll/IL-R immune signal transduction pathways. This protein is primarily expressed in monocytes and macrophages and functions as a negative regulator of Toll-like receptor signaling. Mutations in this gene are associated with a susceptibility to asthma. Alternate splicing results in multiple transcript variants.